1.Diabetes Insipidus Induced by Combination of Short-acting Octreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour: A case report
Goh Kian Guan ; Subashini Rajoo ; Noraini Mohd Dusa ; Nik Hasimah Nik Yahya ; Mohamed Badrulnizam Long Bidin
Journal of the ASEAN Federation of Endocrine Societies 2021;36(2):220-222
Somatostatin analogue is useful in carcinoid crisis for symptom control. Optimal dosing of somatostatin analogues for carcinoid symptoms is not known. This case highlighted management issues using combination short-acting octreotide infusion with long-acting lanreotide during carcinoid crisis. The patient had left lung neuroendocrine tumour that metastasized to his liver and bone, post left lobectomy. Due to extensive metastasis to the liver causing recurrent carcinoid crisis, he required shorter interval long-acting lanreotide with continuous infusion of short-acting octreotide, which led to transient diabetes insipidus. Symptoms resolved with discontinuation of treatment. Somatostatin analogues, especially in combination, may inhibit the posterior pituitary resulting in diabetes insipidus. Prompt withdrawal of short-acting somatostatin analogue and initiation of desmopressin can reverse the complication. It is important to recognize this complication with combination of octreotide and lanreotide injections to avoid serious complications.
Diabetes Insipidus
;
Octreotide
;
Neuroendocrine Tumors
;
Malignant Carcinoid Syndrome
2.Collision adenoma-carcinoid tumour of the colon complicated by carcinoid syndrome.
Singapore medical journal 2012;53(9):e195-7
Tumours consisting of a glandular component, either an adenoma or adenocarcinoma, and a carcinoid component are uncommon. These tumours can be differentiated into collision, composite or amphicrine tumours. Most cases reported in the literature were mixed adenocarcinoma-carcinoid tumours. To date, only four cases of mixed adenoma carcinoid tumours have been reported in the literature. This case report describes a unique case of collision adenoma-carcinoid tumour in the colon complicated by carcinoid syndrome in a 45-year-old woman who presented with a one-month history of diarrhoea and weight loss. She developed recurrence of the carcinoid component of the tumour four months after endoscopic resection. We conclude that carcinoid syndrome can occur in an adenoma-carcinoid tumour; however, the prognosis of this condition is uncertain.
Adenoma
;
pathology
;
Carcinoid Tumor
;
pathology
;
Colonic Neoplasms
;
pathology
;
Colonoscopy
;
Diarrhea
;
etiology
;
Female
;
Humans
;
Malignant Carcinoid Syndrome
;
pathology
;
Middle Aged
;
Weight Loss